Antonini, AngeloPahwa, RajeshOdin, PerHenriksen, ToveSoileau, Michael J.Rodriguez-Cruz, RamonIsaacson, Stuart H.Merola, AristideLindvall, SusannaDomingos, JosefaAlobaidi, AliJalundhwala, Yash J.Kandukuri, Prasanna L.Parra, Juan CarlosKukreja, Pavnit K.Onuk, KorayBergmann, LarsPike, JamesChaudhuri, K. Ray2025-11-262025-11-262022-03Antonini, A., Pahwa, R., Odin, P. et al. Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries. Neurol Ther 11, 303–318 (2022). https://doi.org/10.1007/s40120-021-00313-92193-6536http://hdl.handle.net/10400.26/60036Introduction: Standardized and validated criteria to define advanced Parkinson’s disease (PD) or identify patient eligibility for device-aided therapy are needed. This study assessed the psychometric properties of clinical indicators of advanced PD and eligibility for device-aided therapy in a large population. Methods: This retrospective analysis of the Adelphi Parkinson’s Disease Specific Programme collected data from device-aided therapy-naïve people with PD in G7 countries. We assessed the presence of 15 clinical indicators of advancing PD and seven indicators of eligibility for device-aided therapy in patients classified with advanced PD or as eligible for device-aided therapy by the treating physician. Accuracy was assessed using area under the curve (AUC) and multivariable logistic regression models. Construct validity was examined via known-group comparisons of disease severity and burden among patients with and without each clinical indicator. Results: Of 4714 PD patients, 14.9% were classified with advanced PD and 17.5% as eligible for device-aided therapy by physician judgment. The presence of each clinical indicator was 1.9- to 7.3-fold more likely in patients classified with advanced PD. Similarly, the presence of device-aided therapy eligibility indicators was 1.8- to 5.5-fold more likely in patients considered eligible for device-aided therapy. All indicators demonstrated high clinical screening accuracy for identifying advanced PD (AUC range 0.84–0.89) and patients eligible for device-aided therapy (AUC range 0.73–0.80). The Unified Parkinson’s Disease Rating Scale (UPDRS) score, cognitive function, quality of life, and caregiver burden were significantly worse in indicator-positive patients. Conclusion: Specific clinical indicators of advanced PD and eligibility for device-aided therapy demonstrated excellent psychometric properties in a large sample, and thus may provide an objective and reliable approach for patient identification and treatment optimization.engAdvanced Parkinson’s diseaseClinical indicatorsDevice-aided therapy eligibilityAccuracyValiditycontribution to journal10.1007/s40120-021-00313-9